Inventurus Knowledge Solutions Share Price
1754.20+21.80 (+1.26%)
+11.61% past 1 Year
Inventurus Knowledge Solutions is a technology-enabled healthcare solutions provider and offers a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US
Corporate filings & documents
Announcements
Enclosed is the Newspaper Publication regarding e-voting information for 20th Annual General Meeting of the Company.
6 days agoEnclosed is the Newspaper Publication regarding e-voting information for 20th Annual General Meeting of the Company.
6 days agoLetter sent to members pursuant to Regulation 36(1)(b) of SEBI Listing Regulations is enclosed.
6 days agoLetter sent to members pursuant to Regulation 36(1)(b) of SEBI Listing Regulations is enclosed.
6 days agoBusiness Responsibility and Sustainability Report for FY 2025-26 is enclosed.
1 week agoBusiness Responsibility and Sustainability Report for FY 2025-26 is enclosed.
1 week agoNotice of 20th AGM of the Company to be held on Monday September 21 2026 at 5.30 pm IST is enclosed.
1 week agoNotice of 20th AGM of the Company to be held on Monday September 21 2026 at 5.30 pm IST is enclosed.
1 week agoNotice convening the 20th Annual General Meeting (AGM) and Annual Report 2025-26.We hereby inform you that the 20th AGM of the Company will be held on Monday September 21 2026 at 5.30 p.m. IST through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). Pursuant to Regulation 30 and 34 read with Paragraph A of Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR) we are enclosing herewith the following:1. Annual Report of the Company for the Financial Year (FY) 2025-26.2. Notice of AGM of the Company (including e-voting instructions).
1 week agoNotice convening the 20th Annual General Meeting (AGM) and Annual Report 2025-26.We hereby inform you that the 20th AGM of the Company will be held on Monday September 21 2026 at 5.30 p.m. IST through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). Pursuant to Regulation 30 and 34 read with Paragraph A of Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR) we are enclosing herewith the following:1. Annual Report of the Company for the Financial Year (FY) 2025-26.2. Notice of AGM of the Company (including e-voting instructions).
1 week agoEnclosed is disclosure of newspaper publication.
2 weeks agoEnclosed is disclosure of newspaper publication.
2 weeks agoRef: Our intimation dated August 11 2026 for Schedule of Analyst/ Institutional Investor Meet.Sub: Change in Schedule of Analyst/ Institutional Investor Meet.In continuation of our earlier intimation dated August 11 2026 regarding Analyst/Institutional Investor Meet scheduled on August 18 2026. The said Analyst/Institutional Investor Meet is now rescheduled to August 19 2026.
3 weeks agoRef: Our intimation dated August 11 2026 for Schedule of Analyst/ Institutional Investor Meet.Sub: Change in Schedule of Analyst/ Institutional Investor Meet.In continuation of our earlier intimation dated August 11 2026 regarding Analyst/Institutional Investor Meet scheduled on August 18 2026. The said Analyst/Institutional Investor Meet is now rescheduled to August 19 2026.
3 weeks agoRef: Our intimation dated August 11 2026 for Schedule of Analyst/ Institutional Investor Meet. Sub: Schedule of Analyst/ Institutional Investor Meet - Update.In continuation to our intimation dated August 11 2026 regarding the schedule of the Analyst / Institutional Investor Meet of the Company we hereby inform you that Temasek has been added as an additional institutional investor participating in the Analyst/ Institutional Investor Meet scheduled to be held on August 14 2026. Accordingly the updated schedule is mentioned in the attached intimation.
3 weeks agoRef: Our intimation dated August 11 2026 for Schedule of Analyst/ Institutional Investor Meet. Sub: Schedule of Analyst/ Institutional Investor Meet - Update.In continuation to our intimation dated August 11 2026 regarding the schedule of the Analyst / Institutional Investor Meet of the Company we hereby inform you that Temasek has been added as an additional institutional investor participating in the Analyst/ Institutional Investor Meet scheduled to be held on August 14 2026. Accordingly the updated schedule is mentioned in the attached intimation.
3 weeks agoTranscript of the Q1 FY 2026-27 Earnings Conference Call.Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the transcript of the earnings conference call held on Thursday August 6 2026 with respect to the Companys financial results for the quarter ended June 30 2026.The said transcript has also been uploaded on the Companys website and can be accessed through the link provided in the attached disclosure.
3 weeks agoIn terms of Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you of the Schedule of the Analyst / Institutional Investor Meet of the Company as disclosed in the enclosed intimation.
3 weeks agoIn terms of Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you of the Schedule of the Analyst / Institutional Investor Meet of the Company as disclosed in the enclosed intimation.
3 weeks agoIn terms of Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you of the Schedule of the Analyst / Institutional Investor Meet of the Company as disclosed in the enclosed intimation.
3 weeks agoIn terms of Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you of the Schedule of the Analyst / Institutional Investor Meet of the Company as disclosed in the enclosed intimation.
3 weeks agoEnclosed is outcome of postal ballot voting results and scrutinizers report.
3 weeks agoEnclosed is outcome of postal ballot voting results and scrutinizers report.
3 weeks agoEnclosed is postal ballot voting results and scrutinizers report.
3 weeks agoEnclosed is postal ballot voting results and scrutinizers report.
3 weeks agoEnclosed is the newspaper publication of unaudited financial results of the Company for the quarter ended June 30 2026.
4 weeks agoEnclosed is the newspaper publication of unaudited financial results of the Company for the quarter ended June 30 2026.
4 weeks agoAudio recording of the Earnings Conference Call held on Thursday August 06 2026.This is in continuation of our earlier letter dated July 31 2026 and pursuant to Regulation 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we hereby inform you that the audio recording of the Companys Earnings Conference Call for Q1 FY 2026-27 Results held on Thursday August 06 2026 has been made available on the Companys website. The audio recording of the Conference Call can be accessed at: https://ikshealth.com/ir/2027/q1/q1-earnings-call-recording.mp3This is for your information and records.
4 weeks agoAudio recording of the Earnings Conference Call held on Thursday August 06 2026.This is in continuation of our earlier letter dated July 31 2026 and pursuant to Regulation 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we hereby inform you that the audio recording of the Companys Earnings Conference Call for Q1 FY 2026-27 Results held on Thursday August 06 2026 has been made available on the Companys website. The audio recording of the Conference Call can be accessed at: https://ikshealth.com/ir/2027/q1/q1-earnings-call-recording.mp3This is for your information and records.
4 weeks agoEnclosed is disclosure with respect to agreement entered into.
4 weeks agoEnclosed is disclosure with respect to agreement entered into.
4 weeks agoEnclosed is disclosure with respect to change in directors of the company.
4 weeks agoEnclosed.
4 weeks agoEnclosed is the investor presentation.
4 weeks agoEnclosed is the investor presentation.
4 weeks agoEnclosed is the press release.
4 weeks agoEnclosed is the press release.
4 weeks agoThe Unaudited Standalone and Consolidated Financial results for the quarter ended June 30 2026 is enclosed.
4 weeks agoPursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODRRegulations) we hereby inform that the Board of Directors of Inventurus Knowledge Solutions Limited(the Company) at its meeting held today i.e. August 5 2026 inter alia considered and approved thefollowing:1. Approval of Financial Results2. Retirement of Mr. Berjis Desai Non-Executive Chairman and Non-Independent Director (DIN: 00153675) with effect from conclusion of ensuing 20th Annual General Meeting (AGM)3. Designate Mr. Clarence Carleton King II Independent Director as Non-Executive Chairman and Independent Director of the Company with effect from conclusion of ensuing 20th Annual General Meeting (AGM)
4 weeks agoPursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODRRegulations) we hereby inform that the Board of Directors of Inventurus Knowledge Solutions Limited(the Company) at its meeting held today i.e. August 5 2026 inter alia considered and approved thefollowing:1. Approval of Financial Results2. Retirement of Mr. Berjis Desai Non-Executive Chairman and Non-Independent Director (DIN: 00153675) with effect from conclusion of ensuing 20th Annual General Meeting (AGM)3. Designate Mr. Clarence Carleton King II Independent Director as Non-Executive Chairman and Independent Director of the Company with effect from conclusion of ensuing 20th Annual General Meeting (AGM)
4 weeks agoEnclosed is intimation about update on acquisition.
1 month agoEnclosed is the intimation of earnings conference call - Q1 2026-27 results.
1 month agoEnclosed is the intimation of earnings conference call - Q1 2026-27 results.
1 month agoEnclosed is disclosure with respect to incorporation of step-down wholly owned subsidiary.
1 month agoEnclosed is disclosure with respect to incorporation of step-down wholly owned subsidiary.
1 month agoInventurus Knowledge Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2026.Further in continuation of our earlier letter dated June 26 2026 under subject Intimation of closure of Trading Window and in terms of the Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons and SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in the securities of the Company by the Designated Persons of the Company and/or their immediate relatives shall remain closed from July 1 2026 till August 07 2026 (both days inclusive) for the purpose of said financial results.
1 month agoInventurus Knowledge Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2026.Further in continuation of our earlier letter dated June 26 2026 under subject Intimation of closure of Trading Window and in terms of the Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons and SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in the securities of the Company by the Designated Persons of the Company and/or their immediate relatives shall remain closed from July 1 2026 till August 07 2026 (both days inclusive) for the purpose of said financial results.
1 month agoEnclosed is intimation about update on additional investment in WWMG MSO LLC .
1 month agoEnclosed is intimation about update on additional investment in WWMG MSO LLC .
1 month agoEnclosed is intimation about update on acquisition.
1 month agoConcalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Oct 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Building No. 5 & 6, Unit No. 801, 8th Floor Mindspace S E Z, Thane Belapur Road Airoli, Navi Mumbai Thane Maharashtra PIN: 400708 Tel No: 022-30711100 / 39643205 Fax No: 022-66466879 Email: [email protected] Internet: www.ikshealth.com
Registrars
PIN: Tel No: Fax No: Email:
Management
Sameer Chavan, Company Secretary & Compliance Officer
Berjis Desai, Chairman
Mary Earley Klotman, Non Executive Director
Keith Anthony Jones, Non Executive Independent Director
Amit Goela, Nominee Director
Sachin Gupta, Promoter & Non-Executive Director
Joseph Benardello, Non Executive Director
Clarence Carleton King II, Non Executive Independent Director
Theresa Stone, Non Executive Independent Director
Utpal Sheth, Nominee Director
Nithya Balasubramanian, Whole Time Director
Garheng Kong, Non Executive Independent Director
Details
BSE 544309
NSE IKS
ISIN INE115Q01022